{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:11:53Z","timestamp":1788617513785,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is the most common form of dementia, characterized by accumulation of amyloid \u03b2\u00a0(A\u03b2) and neurofibrillary tangles. Oxidative stress and inflammation are considered to play an important role in the development and progression of AD. However, the extent to which these events contribute to the A\u03b2 pathologies remains unclear. We performed inter-species comparative gene expression profiling between AD patient brains and the<jats:italic>App<\/jats:italic><jats:sup>NL-G-F\/NL-G-F<\/jats:sup>and 3xTg-AD-H mouse models. Genes commonly altered in<jats:italic>App<\/jats:italic><jats:sup>NL-G-F\/NL-G-F<\/jats:sup>and human AD cortices correlated with the inflammatory response or immunological disease. Among them, expression of AD-related genes (<jats:italic>C4a<\/jats:italic>\/<jats:italic>C4b<\/jats:italic>,<jats:italic>Cd74<\/jats:italic>,<jats:italic>Ctss<\/jats:italic>,<jats:italic>Gfap<\/jats:italic>,<jats:italic>Nfe2l2<\/jats:italic>,<jats:italic>Phyhd1<\/jats:italic>,<jats:italic>S100b<\/jats:italic>,<jats:italic>Tf<\/jats:italic>,<jats:italic>Tgfbr2<\/jats:italic>, and<jats:italic>Vim<\/jats:italic>) was increased in the<jats:italic>App<\/jats:italic><jats:sup>NL-G-F\/NL-G-F<\/jats:sup>cortex as A\u03b2 amyloidosis progressed with exacerbated gliosis, while genes commonly altered in the 3xTg-AD-H and human AD cortices correlated with neurological disease. The<jats:italic>App<\/jats:italic><jats:sup>NL-G-F\/NL-G-F<\/jats:sup>cortex also had altered expression of genes (<jats:italic>Abi3<\/jats:italic>,<jats:italic>Apoe<\/jats:italic>,<jats:italic>Bin2<\/jats:italic>,<jats:italic>Cd33<\/jats:italic>,<jats:italic>Ctsc<\/jats:italic>,<jats:italic>Dock2<\/jats:italic>,<jats:italic>Fcer1g<\/jats:italic>,<jats:italic>Frmd6<\/jats:italic>,<jats:italic>Hck<\/jats:italic>,<jats:italic>Inpp5D<\/jats:italic>,<jats:italic>Ly86<\/jats:italic>,<jats:italic>Plcg2<\/jats:italic>,<jats:italic>Trem2<\/jats:italic>,<jats:italic>Tyrobp<\/jats:italic>) defined as risk factors for AD by genome-wide association study or identified as genetic nodes in late-onset AD. These results suggest a strong correlation between cortical A\u03b2 amyloidosis and the neuroinflammatory response and provide a better understanding of the involvement of gender effects in the development of AD.<\/jats:p>","DOI":"10.1038\/s41598-017-17999-3","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T10:01:49Z","timestamp":1513159309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":144,"title":["Comparative profiling of cortical gene expression in Alzheimer\u2019s disease patients and mouse models demonstrates a link between amyloidosis and neuroinflammation"],"prefix":"10.1038","volume":"7","author":[{"given":"Erika","family":"Castillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3515-6606","authenticated-orcid":false,"given":"Guianfranco","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nona","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Haruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-9251","authenticated-orcid":false,"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaomi","family":"Saido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Hokama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-870X","authenticated-orcid":false,"given":"Toru","family":"Iwaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiharu","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Kiyohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Sakumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank M.","family":"LaFerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-242X","authenticated-orcid":false,"given":"Yusaku","family":"Nakabeppu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"17999_CR1","unstructured":"Prince, M., Comas-Herrera, A., Knapp, M., Guerchet, M. & Karagiannidou, M. World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. Alzheimer\u2019s Disease International (ADI), London, UK (2016)."},{"key":"17999_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth, H. W. & LaFerla, F. M. Alzheimer\u2019s Disease. N Engl J Med 362, 329\u2013344 (2010).","journal-title":"N Engl J Med"},{"key":"17999_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mad.2016.05.005","volume":"161","author":"N Abolhassani","year":"2017","unstructured":"Abolhassani, N. et al. Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer\u2019s disease brain. Mech Ageing Dev 161, 95\u2013104 (2017).","journal-title":"Mech Ageing Dev"},{"key":"17999_CR4","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","volume":"12","author":"V Calsolaro","year":"2016","unstructured":"Calsolaro, V. & Edison, P. Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions. Alzheimers Dement 12, 719\u2013732 (2016).","journal-title":"Alzheimers Dement"},{"key":"17999_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nrn3880","volume":"16","author":"FL Heppner","year":"2015","unstructured":"Heppner, F. L., Ransohoff, R. M. & Becher, B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci 16, 358\u2013372 (2015).","journal-title":"Nat Rev Neurosci"},{"key":"17999_CR6","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jneuroim.2013.01.002","volume":"256","author":"R Zhang","year":"2013","unstructured":"Zhang, R. et al. Systemic immune system alterations in early stages of Alzheimer\u2019s disease. J Neuroimmunol 256, 38\u201342 (2013).","journal-title":"J Neuroimmunol"},{"key":"17999_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainresbull.2015.12.003","volume":"122","author":"KD Onos","year":"2016","unstructured":"Onos, K. D., Sukoff Rizzo, S. J., Howell, G. R. & Sasner, M. Toward more predictive genetic mouse models of Alzheimer\u2019s disease. Brain Res Bull 122, 1\u201311 (2016).","journal-title":"Brain Res Bull"},{"key":"17999_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1021\/cn500105p","volume":"5","author":"P Nilsson","year":"2014","unstructured":"Nilsson, P., Saito, T. & Saido, T. C. New Mouse Model of Alzheimer\u2019s. ACS Chem Neurosci 5, 499\u2013502 (2014).","journal-title":"ACS Chem Neurosci"},{"key":"17999_CR9","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neurobiolaging.2014.09.029","volume":"36","author":"F Kametani","year":"2015","unstructured":"Kametani, F. & Haga, S. Accumulation of carboxy-terminal fragments of APP increases phosphodiesterase 8B. Neurobiol Aging 36, 634\u2013637 (2015).","journal-title":"Neurobiol Aging"},{"key":"17999_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nn.3697","volume":"17","author":"T Saito","year":"2014","unstructured":"Saito, T. et al. Single App knock-in mouse models of Alzheimer\u2019s disease. Nat Neurosci 17, 661\u2013663 (2014).","journal-title":"Nat Neurosci"},{"key":"17999_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.nlm.2016.07.001","volume":"135","author":"A Masuda","year":"2016","unstructured":"Masuda, A. et al. Cognitive deficits in single App knock-in mouse models. Neurobiol Learn Mem 135, 73\u201382 (2016).","journal-title":"Neurobiol Learn Mem"},{"key":"17999_CR12","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1212\/WNL.0000000000003322","volume":"87","author":"PS Weston","year":"2016","unstructured":"Weston, P. S. et al. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study. Neurology 87, 2050\u20132057 (2016).","journal-title":"Neurology"},{"key":"17999_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2967\/jnumed.110.087031","volume":"53","author":"SF Carter","year":"2012","unstructured":"Carter, S. F. et al. Evidence for astrocytosis in Prodromal Alzheimer Disease Provided by 11C-deuterium-L-deprenyl: A Multitracer PET Paradigm Combining 11C-Pittsburgh Compound B and 18F-FDG. J Nucl Med 53, 37\u201346 (2012).","journal-title":"J Nucl Med"},{"key":"17999_CR14","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00259-013-2620-7","volume":"41","author":"H Ito","year":"2014","unstructured":"Ito, H. et al. Imaging of amyloid deposition in human brain using positron emission tomography and [18F]FACT: comparison with [11C]PIB. Eur J Nucl Med Mol Imaging 41, 745\u2013754 (2014).","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"17999_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s00401-009-0485-4","volume":"117","author":"I Alafuzoff","year":"2009","unstructured":"Alafuzoff, I. et al. Assessment of \u03b2-amyloid deposits in human brain: a study of the BrainNet Europe Consortium. Acta Neuropathol 117, 309\u2013320 (2009).","journal-title":"Acta Neuropathol"},{"key":"17999_CR16","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature08538","volume":"461","author":"RJ Perrin","year":"2009","unstructured":"Perrin, R. J., Fagan, A. M. & Holtzman, D. M. Multimodal techniques for diagnosis and prognosis of Alzheimer\u2019s disease. Nature 461, 916\u2013922 (2009).","journal-title":"Nature"},{"key":"17999_CR17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-Transgenic Model of Alzheimer\u2019s Disease with Plaques and Tangles: Intracellular A\u03b2 and Synaptic Dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"17999_CR18","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1093\/cercor\/bht101","volume":"24","author":"M Hokama","year":"2014","unstructured":"Hokama, M. et al. Altered Expression of Diabetes-Related Genes in Alzheimer\u2019s Disease Brains: The Hisayama Study. Cereb Cortex 24, 2476\u20132488 (2014).","journal-title":"Cereb Cortex"},{"key":"17999_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.35","volume":"4","author":"A Miyashita","year":"2014","unstructured":"Miyashita, A. et al. Genes associated with the progression of neurofibrillary tangles in Alzheimer\u2019s disease. Transl Psychiatry 4, e396, https:\/\/doi.org\/10.1038\/tp.2014.35 (2014).","journal-title":"Transl Psychiatry"},{"key":"17999_CR20","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.1016\/j.neurobiolaging.2014.06.004","volume":"35","author":"M Orre","year":"2014","unstructured":"Orre, M. et al. Isolation of glia from Alzheimer\u2019s mice reveals inflammation and dysfunction. Neurobiol Aging 35, 2746\u20132760 (2014).","journal-title":"Neurobiol Aging"},{"key":"17999_CR21","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12017-013-8269-3","volume":"16","author":"A Armstrong","year":"2014","unstructured":"Armstrong, A. et al. Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer\u2019s Disease. Neuromolecular Med 16, 150\u2013160 (2014).","journal-title":"Neuromolecular Med"},{"key":"17999_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1326-9-33","volume":"9","author":"V Landel","year":"2014","unstructured":"Landel, V. et al. Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer\u2019s disease. Mol Neurodegener 9, 33, https:\/\/doi.org\/10.1186\/1750-1326-9-33 (2014).","journal-title":"Mol Neurodegener"},{"key":"17999_CR23","doi-asserted-by":"crossref","unstructured":"Sims, R. et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet, doi:10.1038\/ng.3916. [Epub ahead of print] (2017).","DOI":"10.1038\/ng.3916"},{"key":"17999_CR24","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3233\/JAD-170062","volume":"58","author":"JB Zhu","year":"2017","unstructured":"Zhu, J. B., Tan, C. C., Tan, L. & Yu, J. T. State of Play in Alzheimer\u2019s Disease Genetics. J Alzheimers Dis 58, 631\u2013659 (2017).","journal-title":"J Alzheimers Dis"},{"key":"17999_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2013.03.030","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang, B. et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer\u2019s disease. Cell 153, 707\u2013720 (2013).","journal-title":"Cell"},{"key":"17999_CR26","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.celrep.2014.12.041","volume":"10","author":"M Matarin","year":"2015","unstructured":"Matarin, M. et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep 10, 633\u2013644 (2015).","journal-title":"Cell Rep"},{"key":"17999_CR27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ajmg.b.32499","volume":"174","author":"AC Naj","year":"2017","unstructured":"Naj, A. C. & Schellenberg, G. D. Alzheimer\u2019s Disease Genetics C. Genomic variants, genes, and pathways of Alzheimer\u2019s disease: An overview. Am J Med Genet B Neuropsychiatr Genet 174, 5\u201326 (2017).","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"2109","key":"17999_CR28","first-page":"e2115","volume":"32","author":"S Walter","year":"2011","unstructured":"Walter, S. et al. A genome-wide association study of aging. Neurobiol Aging 32(2109), e2115\u20132128 (2011).","journal-title":"Neurobiol Aging"},{"key":"17999_CR29","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet 45, 1452\u20131458 (2013).","journal-title":"Nat Genet"},{"key":"17999_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-017-0184-x","volume":"12","author":"AG Efthymiou","year":"2017","unstructured":"Efthymiou, A. G. & Goate, A. M. Late onset Alzheimer\u2019s disease genetics implicates microglial pathways in disease risk. Mol Neurodegener 12, 43 (2017).","journal-title":"Mol Neurodegener"},{"key":"17999_CR31","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1073\/pnas.082107399","volume":"99","author":"AD Smith","year":"2002","unstructured":"Smith, A. D. Imaging the progression of Alzheimer pathology through the brain. Proc Natl Acad Sci USA 99, 4135\u20134137 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"17999_CR32","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan, U. A. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat Neurosci 17, 304\u2013311 (2014).","journal-title":"Nat Neurosci"},{"key":"17999_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cercor\/11.1.1","volume":"11","author":"PM Thompson","year":"2001","unstructured":"Thompson, P. M. et al. Cortical Change in Alzheimer\u2019s Disease Detected with a Disease-specific Population-based Brain Atlas. Cereb Cortex 11, 1\u201316 (2001).","journal-title":"Cereb Cortex"},{"key":"17999_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","volume":"45","author":"LM Billings","year":"2005","unstructured":"Billings, L. M. et al. Intraneuronal A\u03b2 Causes the Onset of Early Alzheimer\u2019s Disease-Related Cognitive Deficits in Transgenic Mice. Neuron 45, 675\u2013688 (2005).","journal-title":"Neuron"},{"key":"17999_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-2011-111529","volume":"28","author":"O Wirths","year":"2012","unstructured":"Wirths, O., Dins, A. & Bayer, T. A. A\u03b2PP Accumulation and\/or Intraneuronal Amyloid-\u03b2 accumulation? The 3xTg-AD Mouse Model Revisited. J Alzheimers Dis 28, 897\u2013904 (2012).","journal-title":"J Alzheimers Dis"},{"key":"17999_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.nicl.2014.11.015","volume":"7","author":"GM Kerbler","year":"2015","unstructured":"Kerbler, G. M. et al. Basal forebrain atrophy correlates with amyloid \u03b2 burden in Alzheimer\u2019s disease. Neuroimage Clin 7, 105\u2013113 (2015).","journal-title":"Neuroimage Clin"},{"key":"17999_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1567205014666170220141822","volume":"14","author":"M Zorzetto","year":"2017","unstructured":"Zorzetto, M. et al. Complement C4A and C4B Gene Copy Number Study in Alzheimer\u2019s Disease Patients. Curr Alzheimer Res 14, 1\u20136 (2017).","journal-title":"Curr Alzheimer Res"},{"key":"17999_CR38","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00702-012-0797-8","volume":"119","author":"J Daborg","year":"2012","unstructured":"Daborg, J. et al. Cerebrospinal fluid levels of complement proteins C3, C4 and CR1 in Alzheimer\u2019s disease. J Neural Transm (Vienna) 119, 789\u2013797 (2012).","journal-title":"J Neural Transm (Vienna)"},{"key":"17999_CR39","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3233\/JAD-2012-112012","volume":"30","author":"M Zabel","year":"2012","unstructured":"Zabel, M. et al. Assessing Candidate Serum Biomarkers for Alzheimer\u2019s Disease: A Longitudinal Study. J Alzheimers Dis 30, 311\u2013321 (2012).","journal-title":"J Alzheimers Dis"},{"key":"17999_CR40","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.neurobiolaging.2012.11.008","volume":"34","author":"KT Wirz","year":"2013","unstructured":"Wirz, K. T. et al. Cortical beta amyloid protein triggers an immune response, but no synaptic changes in the APPswe\/PS1dE9 Alzheimer\u2019s disease mouse model. Neurobiol Aging 34, 1328\u20131342 (2013).","journal-title":"Neurobiol Aging"},{"key":"17999_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.it.2008.11.003","volume":"30","author":"AP Sjoberg","year":"2009","unstructured":"Sjoberg, A. P., Trouw, L. A. & Blom, A. M. Complement activation and inhibition: a delicate balance. Trends Immunol 30, 83\u201390 (2009).","journal-title":"Trends Immunol"},{"key":"17999_CR42","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.aad8373","volume":"352","author":"S Hong","year":"2016","unstructured":"Hong, S. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 352, 712\u2013716 (2016).","journal-title":"Science"},{"key":"17999_CR43","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/nri3761","volume":"14","author":"M Kolev","year":"2014","unstructured":"Kolev, M., Le Friec, G. & Kemper, C. Complement - tapping into new sites and effector systems. Nat Rev Immunol 14, 811\u2013820 (2014).","journal-title":"Nat Rev Immunol"},{"key":"17999_CR44","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cytogfr.2012.08.001","volume":"24","author":"MD Sanchez-Nino","year":"2013","unstructured":"Sanchez-Nino, M. D. et al. MIF, CD74 and other partners in kidney disease: Tales of a promiscuous couple. Cytokine Growth Factor Rev 24, 23\u201340 (2013).","journal-title":"Cytokine Growth Factor Rev"},{"key":"17999_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1326-3-13","volume":"3","author":"KJ Bryan","year":"2008","unstructured":"Bryan, K. J. et al. Expression of CD74 is increased in neurofibrillary tangles in Alzheimer\u2019s disease. Mol Neurodegener 3, 13, https:\/\/doi.org\/10.1186\/1750-1326-3-13 (2008).","journal-title":"Mol Neurodegener"},{"key":"17999_CR46","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.neurobiolaging.2014.09.027","volume":"36","author":"S Sekar","year":"2015","unstructured":"Sekar, S. et al. Alzheimer\u2019s disease is associated with altered expression of genes involved in immune response and mitochondrial processes in astrocytes. Neurobiol Aging 36, 583\u2013591 (2015).","journal-title":"Neurobiol Aging"},{"key":"17999_CR47","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/mt.2015.142","volume":"23","author":"T Kiyota","year":"2015","unstructured":"Kiyota, T. et al. AAV2\/1 CD74 Gene Transfer Reduces \u03b2-amyloidosis and Improves Learning and Memory in a Mouse Model of Alzheimer\u2019s Disease. Mol Ther 23, 1712\u20131721 (2015).","journal-title":"Mol Ther"},{"key":"17999_CR48","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1326-4-41","volume":"4","author":"S Matsuda","year":"2009","unstructured":"Matsuda, S., Matsuda, Y. & D\u2019Adamio, L. CD74 interacts with APP and suppresses the production of A\u03b2. Mol Neurodegener 4, 41, https:\/\/doi.org\/10.1186\/1750-1326-4-41 (2009).","journal-title":"Mol Neurodegener"},{"key":"17999_CR49","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S1074-7613(00)80249-6","volume":"4","author":"RJ Riese","year":"1996","unstructured":"Riese, R. J. et al. Essential Role for Cathepsin S in MHC class II-Associated Invariant Chain Processing and Peptide Loading. Immunity 4, 357\u2013366 (1996).","journal-title":"Immunity"},{"key":"17999_CR50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1074-7613(02)00455-7","volume":"17","author":"D Matza","year":"2002","unstructured":"Matza, D., Kerem, A., Medvedovsky, H., Lantner, F. & Shachar, I. Invariant Chain-Induced B Cell Differentiation Requires Intramembrane Proteolytic Release of the Cytosolic Domain. Immunity 17, 549\u2013560 (2002).","journal-title":"Immunity"},{"key":"17999_CR51","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/bj3110299","volume":"311","author":"JS Munger","year":"1995","unstructured":"Munger, J. S. et al. Lysosomal processing of amyloid precursor protein to A\u03b2 peptides: a distinct role for cathepsin S. Biochemical Journal 311, 299\u2013305 (1995).","journal-title":"Biochemical Journal"},{"key":"17999_CR52","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/jnr.23827","volume":"95","author":"CJ Pike","year":"2017","unstructured":"Pike, C. J. Sex and the Development of Alzheimer\u2019s disease. J Neurosci Res 95, 671\u2013680 (2017).","journal-title":"J Neurosci Res"},{"key":"17999_CR53","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.jalz.2016.08.004","volume":"12","author":"HM Snyder","year":"2016","unstructured":"Snyder, H. M. et al. Sex biology contributions to vulnerability to Alzheimer\u2019s disease: A think tank convened by the Women\u2019s Alzheimer\u2019s Research Initiative. Alzheimers Dement 12, 1186\u20131196 (2016).","journal-title":"Alzheimers Dement"},{"key":"17999_CR54","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.matbio.2016.05.003","volume":"56","author":"Z Piperigkou","year":"2016","unstructured":"Piperigkou, Z. et al. Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules. Matrix Biol 56, 4\u201323 (2016).","journal-title":"Matrix Biol"},{"key":"17999_CR55","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.yfrne.2013.08.001","volume":"35","author":"JR Rettberg","year":"2014","unstructured":"Rettberg, J. R., Yao, J. & Brinton, R. D. Estrogen: A master regulator of bioenergetic systems in the brain and body. Front Neuroendocrinol 35, 8\u201330 (2014).","journal-title":"Front Neuroendocrinol"},{"key":"17999_CR56","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/0008-5472.CAN-14-1583","volume":"75","author":"S Busch","year":"2015","unstructured":"Busch, S., Sims, A. H., Stal, O., Ferno, M. & Landberg, G. Loss of TGF\u03b2 Receptor Type 2 Expression Impairs Estrogen Response and Confers Tamoxifen Resistance. Cancer Res 75, 1457\u20131469 (2015).","journal-title":"Cancer Res"},{"key":"17999_CR57","doi-asserted-by":"crossref","unstructured":"Chen, Y., Zhang, K., Li, Y. & He, Q. Estrogen-related receptor \u03b1 participates transforming growth factor-\u03b2 (TGF-\u03b2) induced epithelial-mesenchymal transition of osteosarcoma cells. Cell Adh Migr, 1\u20139 (2016).","DOI":"10.1080\/19336918.2016.1221567"},{"key":"17999_CR58","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/nn.3560","volume":"16","author":"AR Bialas","year":"2013","unstructured":"Bialas, A. R. & Stevens, B. TGF-\u03b2 signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci 16, 1773\u20131782 (2013).","journal-title":"Nat Neurosci"},{"key":"17999_CR59","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.4049\/jimmunol.153.11.5210","volume":"153","author":"EN Benveniste","year":"1994","unstructured":"Benveniste, E. N. et al. Differential Modulation of Astrocyte Cytokine Gene Expression by TGF-\u03b2. J Immunol 153, 5210\u20135221 (1994).","journal-title":"J Immunol"},{"key":"17999_CR60","unstructured":"Pfaffi, M. W. Relative quantification, in real-time PCR (ed. Dorak M. T), Taylor & Francis Group, NY, pp63\u201382, 2006."}],"updated-by":[{"DOI":"10.1038\/s41598-021-97918-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17999-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17999-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T22:01:57Z","timestamp":1693346517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-17999-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["17999"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-17999-3","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-021-97918-9","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"13 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-97918-9","URL":"https:\/\/doi.org\/10.1038\/s41598-021-97918-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17762"}}